Bovine intestinal alkaline phosphatase - Alloksys Life Sciences

Drug Profile

Bovine intestinal alkaline phosphatase - Alloksys Life Sciences

Alternative Names: bIAP; bovine RESCAP® - Alloksys; bRESCAP

Latest Information Update: 03 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alloksys Life Sciences
  • Class Phosphoric monoester hydrolases
  • Mechanism of Action Cytokine modulators; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Ischaemia
  • No development reported Rheumatoid arthritis

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 03 Jun 2016 Bovine intestinal alkaline phosphatase is still in phase III trials for Ischaemia in Belgium and Netherlands
  • 03 Jun 2016 Interim efficacy data from a phase IIIa trial in Ischaemia released by Alloksys before June 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top